From mint · Vaamanaa Sethi · · 1m 30s
Sakar Healthcare stock up 4.5% after Q2 results
Sakar Healthcare shares rise 4.5% post-Q2 results as experts debate rally continuation.
In brief
Sakar Healthcare shares rise 4.5% post-Q2 results as experts debate rally continuation. Sakar Healthcare stock rose 4.5% after reporting 149% YoY net profit growth in Q2 FY27, with analysts debating whether the rally will continue. Originally reported by mint.
Sakar Healthcare shares open
Sakar Healthcare shares opened at ₹ 943.50 per share today, compared to ₹ 885 on Friday last week.
Short-term performance
Sakar Healthcare shares declined 17.81% over the past month but gained 1.12% in the past week.
Long-term gains
Sakar Healthcare has surged 503.82% over five years, with 182.79% growth in three years.
Q2 FY27 results
Sakar Healthcare reported 149% YoY net profit growth to ₹ 11.30 crore, with EBITDA rising 114% to ₹ 24.34 crore.
Q2 FY27 drivers
Growth driven by new oncology approvals, robust demand across geographies, improved product mix, and cost management.
H1 FY27 results
Sakar Healthcare recorded 134% YoY net profit growth to ₹ 21.59 crore, with EBITDA rising 90% to ₹ 45.59 crore.
Management statement
Sanjay Shah, Managing Director, said Q2 FY27 brought meaningful progress in oncology with regulatory approvals and global market access.
Lemonn technical view
Gaurav Garg notes the stock is trading around ₹ 943.40 after rebounding from ₹ 870, 880 support, with ₹ 980 as key resistance.
Kantilal Chhaganlal Securities view
Mahesh M Ojha identifies ₹ 824, 800 as crucial support and ₹ 980 as immediate resistance for Sakar Healthcare.
The headline
Sakar Healthcare stock rose 4.5% after reporting 149% YoY net profit growth in Q2 FY27, with analysts debating whether the rally will continue.
